PRESS RELEASE published on 12/06/2024 at 16:02, 1 year 9 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.48% stake in Direct Line Insurance Group plc. Additional disclosure for cash offer related to Aviva plc Disclosure The Vanguard Group Stake Direct Line Insurance Group Plc Aviva Plc
BRIEF published on 12/05/2024 at 15:19, 1 year 9 months ago The Vanguard Group's Position in Direct Line Insurance Group Takeover Code Securities Disclosure Vanguard Group Share Transactions Direct Line Insurance
BRIEF published on 12/05/2024 at 15:19, 1 year 9 months ago Position du groupe Vanguard dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Transactions Sur Actions Divulgation Des Valeurs Mobilières Assurance Ligne Directe
PRESS RELEASE published on 12/05/2024 at 15:14, 1 year 9 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.45% ownership in Direct Line Insurance Group plc as of 04 December 2024. Additional disclosure on dealings provided Financial Dealings The Vanguard Group Ownership Disclosure Direct Line Insurance Group Plc Stock Market Disclosure
BRIEF published on 12/04/2024 at 15:22, 1 year 9 months ago Vanguard Group Discloses Interests in Direct Line Insurance Takeover Code Vanguard Group Shareholding Disclosure Investment Position Direct Line
BRIEF published on 12/04/2024 at 15:22, 1 year 9 months ago Le groupe Vanguard révèle ses participations dans Direct Line Insurance Groupe Vanguard Code De Prise De Contrôle Divulgation Des Actions Position D'investissement Ligne Directe
PRESS RELEASE published on 12/04/2024 at 15:17, 1 year 9 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.45% stake in Direct Line Insurance Group plc as of 03-Dec-2024, including stock purchases and sales. Disclosure under Rule 8.3 of Takeover Code Rule 8.3 Vanguard Group Inc. Stake Disclosure Stock Transactions Direct Line Insurance Group Plc
BRIEF published on 12/03/2024 at 15:23, 1 year 9 months ago Vanguard Group Discloses Interest in Direct Line Insurance Disclosure Takeover Code Shareholding Vanguard Direct Line
BRIEF published on 12/03/2024 at 15:23, 1 year 9 months ago Le groupe Vanguard révèle son intérêt pour Direct Line Insurance Actionnariat Code De Prise De Contrôle Divulgation Avant-garde Ligne Directe
PRESS RELEASE published on 12/03/2024 at 15:18, 1 year 9 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.45% stake in Direct Line Insurance Group plc as of 02 December 2024 according to Form 8.3 filing Form 8.3 Vanguard Group Stake Disclosure Financial Holdings Direct Line Insurance
Published on 09/11/2026 at 04:00, 5 hours 50 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 25 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 30 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 50 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 30 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 45 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 50 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 20 minutes ago Availability of the 2026 Interim Financial Report
